Last reviewed · How we verify
NCT02566980
Biological Triggers of Depression in Pregnancy
trial in Depression and Suicide in 209 participants. Completed in 28 February 2017.
28 February 2017
Quick facts
| Lead sponsor | Michigan State University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 209 |
| Start date | 23 October 2014 |
| Primary completion | 28 February 2017 |
| Estimated completion | 28 February 2017 |
| Sites | 3 locations across United States |
Conditions studied
- Depression and Suicide — all drugs for Depression and Suicide →
- Mood Disorders — all drugs for Mood Disorders →
- Other Perinatal Conditions — all drugs for Other Perinatal Conditions →
Sponsor
Michigan State University
Who can join
18 and older, female only, with Depression and Suicide or Mood Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the study is to define and measure biological processes that contribute to the underlying pathophysiologic process of peri-partum depression to be used for identifying those at risk for developing it. This knowledge may also generate novel drug targets for peripartum depression that may be applicable to other types of depression.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy.
Sha Q, Madaj Z, Keaton S, Escobar Galvis ML, et al · · 2022 · cited 71× · PMID 35078975 · DOI 10.1038/s41398-022-01801-8
Verify or expand the search:
- PubMed search for NCT02566980
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression and Suicide
Currently open trials in the same condition.
- NCT06009523 — Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation · NA · recruiting
- NCT05437588 — Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolesce · NA · recruiting
Other Michigan State University trials
Trials by the same sponsor.
- NCT06325150 — The Impact of Light Exposure on Cognitive Function in Classrooms · Phase 1 · not yet recruiting
- NCT07213284 — Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial · NA · not yet recruiting
- NCT07164391 — Empowering Vietnamese Americans · NA · not yet recruiting
- NCT04521972 — Impact of Room Light on Uterine Contractions and Labor Progression in Pregnancy · NA · recruiting
- NCT05358964 — Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02566980 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Michigan State University
- Last refreshed: 28 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02566980.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing